Author
Listed:
- Patricia I. Jewett
(Department of Medicine, University of Minnesota, Minneapolis, MN, USA)
- Rachel I. Vogel
(Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis, MN, USA
Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA)
- Mary C. Schroeder
(Division of Health Services Research, College of Pharmacy, University of Iowa, Iowa City, IA, USA)
- Joan M. Neuner
(Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA)
- Anne H. Blaes
(Department of Medicine, University of Minnesota, Minneapolis, MN, USA
Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA)
Abstract
Background. Having dependent children may affect cancer treatment decisions. We sought to describe women’s surgery and chemotherapy decisions in nonmetastatic breast cancer by parental status. Methods. We conducted a secondary analysis of the 2015 cross-sectional Share Thoughts on Breast Cancer Study, conducted in 7 Midwestern states in the United States, restricted to women of prime parenting age (aged 20–50 years) who consented to the use of their medical records ( N = 225). We examined treatment decisions using data visualization and logistic regression (adjusted for age, stage, family history of breast cancer, income, education, race, health insurance, and partner status). Results. Women with dependent children received bilateral mastectomy more often than women without dependent children (adjusted odds ratio 3.09, 95% confidence interval 1.44–6.62).We found no differences in the receipt of chemotherapy by parental status. Women reported more active roles in surgery than in chemotherapy decision making. Conclusions. As a likely factor in cancer treatment decisions, parental status should be addressed in clinical practice and research. Future research should assess patients’ sense of ownership in treatment decision making by treatment type.
Suggested Citation
Patricia I. Jewett & Rachel I. Vogel & Mary C. Schroeder & Joan M. Neuner & Anne H. Blaes, 2020.
"Parental Status in Treatment Decision Making among Women with Nonmetastatic Breast Cancer,"
Medical Decision Making, , vol. 40(4), pages 540-544, May.
Handle:
RePEc:sae:medema:v:40:y:2020:i:4:p:540-544
DOI: 10.1177/0272989X20918606
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:40:y:2020:i:4:p:540-544. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.